“…In addition, inhibitors of nitric oxide synthase are known to enhance the extracellular levels of serotonin and dopamine in major brain areas involved in the pathophysiology of depression (Wegener, Volke & Rosenberg, 2000). Clinical studies show an increased production of systemic NO in depressed patients, suggesting their involvement with depressive symptoms (Herken et al, 2007;Talarowska et al, 2012).…”